Effects of Cardiovascular Health Education Program on Community-dwelling Older Adults at Risk of ASCVD
The Effects of a Cardiovascular Health Education Program on Community-dwelling Older Adults at Risk of Atherosclerotic Cardiovascular Diseases: A Pilot Randomized Controlled Trial
1 other identifier
interventional
80
0 countries
N/A
Brief Summary
Despite older adults being exposed to an increased risk of atherosclerotic cardiovascular disease (ASCVD), they are generally underrepresented in cardiovascular prevention programmes. The aim of this study is to assess the feasibility of implementing an integrated exercise and cardiovascular health education programme (HE programme) on older adults at risk of ASCVD.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable cardiovascular-diseases
Started Sep 2021
Typical duration for not_applicable cardiovascular-diseases
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 19, 2021
CompletedFirst Posted
Study publicly available on registry
September 1, 2021
CompletedStudy Start
First participant enrolled
September 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2024
CompletedSeptember 1, 2021
August 1, 2021
3 years
August 19, 2021
August 26, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Physical activity level (total score)
The physical activity level will be measured by the Chinese Version of Physical Activity Scale for the Elderly (PASE-C). The total score (from zero to 400 or above) is quantified based on frequency values and weights for these activities. The higher the score, the higher the level of physical activity.
At baseline, at Week 6, and at Week 12
Physical activity level (classification of physical activity level)
The physical activity level will be measured by the Chinese version of International Physical Activity Questionnaire-short form (IPAQ-C-short form). Participants are classified into "inactive", "minimally active" or "health enhancing physical activity (HEPA) active" based on their physical activity levels.
At baseline, at Week 6, and at Week 12
Secondary Outcomes (17)
Exercise self-efficacy
At baseline, at Week 6, and at Week 12
ASCVD risk profiles (Blood pressure, weight, height, BMI & waist circumference, heart rate)
At baseline, at Week 6, and at Week 12
ASCVD risk profiles (2-minute walk test)
At screening stage, at Week 6, and at Week 12
Acceptability of the program to participants
At Week 12
Acceptability of the program to outcome assessors
After the outcome assessors have finished their duties
- +12 more secondary outcomes
Study Arms (2)
Experimental Arm: Integrated Intervention
EXPERIMENTALReceive an integrated exercise and cardiovascular health education programme (HE programme)
Control
SHAM COMPARATORReceive usual care
Interventions
Participants will receive a 12-week integrated exercise and cardiovascular health education programme (HE programme) which is constructed based on self-efficacy theory. A booster intervention in the form of SMS messaging will be given from Week 1 to Week 12.
Participants will receive usual care which primarily includes an education talk on basic health issues. Governmental health education leaflets will be provided for reference.
Eligibility Criteria
You may qualify if:
- Chinese adults ≧60 years old
- Having at least one ASCVD risk factor
- Pass the cardiovascular fitness evaluation
- Able to write and read Chinese, and communicate in Cantonese;
- Possess a mobile phone and able to make use of the phone in reading SMS
You may not qualify if:
- Visually impaired, hearing impaired, or suffer from cognitive, psychiatric, or muscular disorder
- Having a history of attending similar cardiovascular prevention program
- Having a previous history of coronary heart disease or stroke
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Ka Yan Ho, PhD
The Hong Kong Polytechnic University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
August 19, 2021
First Posted
September 1, 2021
Study Start
September 1, 2021
Primary Completion
September 1, 2024
Study Completion
September 1, 2024
Last Updated
September 1, 2021
Record last verified: 2021-08